Elsevier

Annals of Oncology

Volume 32, Supplement 5, September 2021, Page S1240
Annals of Oncology

1832P Cardiotoxicity of the HER2 dimerisation inhibitor pertuzumab in patients with breast cancer HER2+: A systematic review

https://doi.org/10.1016/j.annonc.2021.08.720Get rights and content
Under an Elsevier user license
open archive

Cited by (0)